Role of Iron Deficiency in Heart Failure-Clinical and Treatment Approach: An Overview.
Cristina Elena SingerCorina Maria VasileMihaela PopescuAlin Iulian Silviu PopescuIulia Cristina MargineanGeorge Alexandru IacobMihai Daniel PopescuCristina Maria MargineanPublished in: Diagnostics (Basel, Switzerland) (2023)
Anemia is frequently encountered in CHF and represents a negative prognostic factor. Data from randomized controlled trials have underlined the administration of intravenous iron therapy (ferric carboxymaltose) as the only viable treatment option, with beneficial effects on quality of life and exercise capacity in patients with ID and systolic heart failure.
Keyphrases
- iron deficiency
- heart failure
- prognostic factors
- left ventricular
- randomized controlled trial
- blood pressure
- physical activity
- chronic kidney disease
- high intensity
- atrial fibrillation
- systematic review
- clinical trial
- high dose
- machine learning
- acute heart failure
- electronic health record
- cell therapy
- data analysis
- double blind